Purpura, Thrombocytopenic, Idiopathic
1 competing product in clinical development for Purpura, Thrombocytopenic, Idiopathic.
Pipeline by Phase
Phase 11
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| E5501 40 mg 2 x 20-mg tablets, orally, fasted + E5501 40 mg 2 x 20-mg tablets, orally, with food + E5501 40mg 2 x 20-mg tablets, orally, fasted + E5501 40 mg 2 x 20-mg tablets, orally, with food | Eisai | Phase 1 | Completed | 29 |